MLSS - Milestone Scientific Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.6615
+0.0314 (+4.98%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.6301
Open0.0000
Bid0.6600 x 800
Ask2.8700 x 4000
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume323,270
Market Cap31.415M
Beta (3Y Monthly)2.51
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • ACCESSWIRE

    Milestone Scientific Provide Business Update and Reports Financial Results for the Second Quarter of 2019

    LIVINGSTON, NJ / ACCESSWIRE / August 15, 2019 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...

  • ACCESSWIRE

    Milestone Scientific Schedules Second Quarter 2019 Conference Call

    LIVINGSTON, NJ / ACCESSWIRE / August 12, 2019 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...

  • ACCESSWIRE

    Milestone Scientific Signs Distribution Agreement with Paragon Care Limited

    Expands availability of the CompuFlo ® Epidural System to anesthesiologists in Australia LIVINGSTON, NJ / ACCESSWIRE / August 5, 2019 / Milestone Scientific Inc . (NYSE American: MLSS ) today signed an ...

  • ACCESSWIRE

    Milestone Scientific's CompuFlo(R) Epidural Instrument Featured in Multiple Abstracts at Euroanaesthesia 2019

    LIVINGSTON, NJ / ACCESSWIRE / June 10, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today shared the results of two research abstracts featuring the CompuFlo® Epidural Instrument (CompuFlo) at Euroanesthesia 2019, Europe's largest annual event showcasing the latest knowledge in the field of anesthesia. The abstracts were presented during scientific poster sessions highlighting how CompuFlo's objective detection of tissue pressure makes challenging procedures with difficult patients more efficient and accelerates clinical competency for trainees. Researchers from Hospital Universitario La Paz in Madrid, Spain shared a case report using CompuFlo for blood patch repairs after an accidental dural puncture in obstetric patients.

  • ACCESSWIRE

    Milestone Scientific Announces Conversion of Convertible Preferred Stock at $1.17 per Share

    LIVINGSTON, NJ / ACCESSWIRE / June 4, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the shares of Series A Preferred Stock held by BP4 S.p.A., an entity affiliated with Gian Domenico Trombetta, a Director of Milestone Scientific and Chief Executive Officer and Director of Wand Dental Inc., a wholly-owned subsidiary of Milestone Scientific, converted into 5,982,906 shares of restricted common stock common on May 14, 2019 at an effective conversion price of $1.17 per share, based on the initial investment amount of $7 million. The Series A Preferred Stock was converted pursuant to the terms and conditions of the Company's Investment Agreement, dated May 14, 2014, with BP4 and the Series A Certificate of Designation.

  • ACCESSWIRE

    Milestone Scientific Unveils CompuFlo(R) Epidural Trainer and Educational Suite at Euroanaesthesia 2019

    Connecting technique and intelligence accelerates clinical competency LIVINGSTON, NJ / ACCESSWIRE / May 30, 2019 / Milestone Scientific Inc. (NYSE: MLSS) today announced that its new CompuFlo ® Epidural ...

  • ACCESSWIRE

    Milestone Scientific Provides Business Update for the First Quarter of 2019

    LIVINSTON, NJ / ACCESSWIRE / May 15, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...

  • ACCESSWIRE

    Milestone Scientific Schedules First Quarter 2019 Conference Call

    LIVINGSTON, NJ / ACCESSWIRE / May 14, 2019 / Milestone Scientific Inc . (NYSE American: MLSS ), today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16, 2019 to ...

  • ACCESSWIRE

    Milestone Scientific Showcases the CompuFlo(R) Epidural Instrument at ASRA 2019

    Connecting Tactile Feel with Intelligence Improves First Attempt Placement for Any Technique LIVINGSTON, NJ / ACCESSWIRE / April 11, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today is presenting ...

  • ACCESSWIRE

    Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman to Board of Directors

    LIVINGSTON, NJ / ACCESSWIRE / April 8, 2019 / Milestone Scientific Inc. (MLSS) today announced that Neal I. Goldman has been appointed to the Company's Board of Directors. Mr. Goldman has also joined the newly formed special committee of the Board, which has been tasked with evaluating strategic options to maximize shareholder value. Mr. Goldman is the President and Founder of Goldman Capital Management, Inc., a family office since 2018, which was previously an investment advisory firm founded in 1985.

  • ACCESSWIRE

    Milestone Scientific Enters Medical Education Market, Inks Distribution Agreement with American 3B Scientific

    LIVINGSTON, NJ / ACCESSWIRE / April 4, 2019 / Milestone Scientific Inc. (MLSS) today enters the medical education market with the introduction of the CompuFlo® Epidural Trainer (CompuFlo Trainer), an instructional instrument that uses pressure sensing technology to improve epidural placement success. The company has signed an agreement to distribute the CompuFlo Trainer with American 3B Scientific, a leading supplier of didactic material for medical education. Epidural space insertion is a difficult procedure to master for medical students.

  • ACCESSWIRE

    Milestone Scientific Reports 70% Year-Over-Year Revenue Growth and Positive Net Income for the Fourth Quarter of 2018

    LIVINGSTON, NJ / ACCESSWIRE / April 2, 2019 / Milestone Scientific Inc . (NYSE American: MLSS ), a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...

  • ACCESSWIRE

    Milestone Scientific Schedules 2018 Year-End Earnings Conference Call

    LIVINGSTON, NJ / ACCESSWIRE / March 29, 2019 / Milestone Scientific Inc . (NYSE American: MLSS ), a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...

  • ACCESSWIRE

    Milestone Scientific Announces Plans to Establish Special Committee of the Board of Directors to Evaluate Strategic Options

    LIVINGSTON, NJ / ACCESSWIRE / March 19, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the Board of Directors plans to establish a special committee of the Board to evaluate strategic options, which could include the potential sale or licensing of different instruments and/or other business combinations. Leslie Bernhard, Chairman of Milestone Scientific, stated, "Our mission has been to develop a portfolio of new technologies around our core platform, the patented DPS Dynamic Pressure Sensing® injection technology, which has the potential to improve success rates, reduce complications and lower costs.

  • GlobeNewswire

    Milestone Scientific Provides Update on CompuFlo® Epidural System Commercial Launch

    CompuFlo is an instrument that helps anesthesiologists objectively identify the epidural space with 99% success on the first attempt. Easier, more reliable identification is essential to reducing costs, failed epidurals and complications.

  • GlobeNewswire

    Milestone Scientific Announces Private Placement by Entity Affiliated with Board Member & CEO of the Company’s Wand Dental Subsidiary

    LIVINGSTON, N.J., Feb. 14, 2019 -- Milestone Scientific Inc. (NYSE: MLSS) today announced that BP4 S.p.A. (“BP4”), a principal stockholder of Milestone Scientific, exercised.

  • GlobeNewswire

    Third Study Verifies Milestone Scientific’s CompuFlo® Instrument Differentiates False Loss of Resistance During Epidural Blocks

    Milestone Scientific Inc. (MLSS) today announced a new 120-patient clinical study published in Anesthesiology Research & Practice that verifies the CompuFlo® Epidural System (“CompuFlo”) consistently differentiates false loss of resistance from true loss of resistance during epidural placement. In all cases where CompuFlo pressure measurements were used to objectively identify the epidural space, the block was performed successfully with no complications. Easier identification of false losses of resistance is essential to reducing the number of epidural attempts and risk of accidental dural puncture.

  • GlobeNewswire

    Pugliese Ciaccio First Hospital in Italy to Adopt Milestone Scientific’s CompuFlo® Instrument

    LIVINGSTON, N.J., Feb. 04, 2019 (GLOBE NEWSWIRE) --  Milestone Scientific Inc. (MLSS) today announced Ospedale “Pugliese Ciaccio” di Catanzaro is the first hospital in Italy to use the CompuFlo® Epidural System (“CompuFlo”) for all epidurals in labor and delivery. For a local hospital performing a limited number of epidurals, CompuFlo offers a real-time, objective tool for accurate epidural space identification to help reduce failure rates and accidental dural punctures that can require further treatment and interventions.

  • GlobeNewswire

    Milestone Scientific Announces Pricing of $2.0 Million Offering of Common Stock and Warrants

    Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 5,715,000 shares of its common stock and warrants to purchase up to an aggregate of 1,428,750 shares of the Company’s common stock, with a purchase price of $0.35 per common stock and warrant.  The warrants will be exercisable immediately at an exercise price of $0.50 per share and will expire five years from the date of issuance. Milestone Scientific has granted the underwriter an over-allotment option, exercisable for a period of 45 days, to purchase up to 857,250 additional shares of its common stock and/or 214,312 warrants. Milestone Scientific intends to use the net proceeds from this offering for general corporate purposes, including working capital.

  • GlobeNewswire

    Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants

    Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it intends to offer for sale a combination of shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. Maxim Group LLC is acting as sole book-running manager for the offering. The securities described above are being offered by Milestone Scientific pursuant to a registration statement (File No. 333-209466) previously filed and declared effective by the Securities and Exchange Commission (SEC).

  • GlobeNewswire

    New Clinical Trial Finds Milestone Scientific’s CompuFlo® Instrument a Safe Alternative to Current Standards of Care

    Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the results of a four hundred patient clinical trial by researchers from the University of Miami, University of Texas and Northwestern University, and two prominent California-based pain clinics.  Published-Ahead-of-Print in Anesthesia & Analgesia (the official Journal of the International Anesthesia Research Society), the randomized, controlled study compared the effectiveness of the CompuFlo® Epidural System (“CompuFlo”) in labor and delivery and chronic pain management, where loss of resistance and fluoroscopy are the current standards of care.

  • GlobeNewswire

    New York Stock Exchange Accepts Milestone Scientific’s Plan to Regain Compliance

    LIVINGSTON, N.J., Jan. 25, 2019 -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise.

  • ACCESSWIRE

    Today's Research Reports on Trending Tickers: Milestone Scientific and Bausch Health

    NEW YORK, NY / ACCESSWIRE / December 13, 2018 / Biotech stocks Milestone Scientific and Bausch Health Companies soared on Wednesday. Milestone Scientific saw big gains of over 20% on no specific news while Bausch Health Companies closed up almost 5% on news that it has entered into a definitive agreement to acquire certain assets of biopharmaceutical company Synergy Pharmaceuticals Inc. Milestone Scientific, Inc. shares closed up 22.73% on about 3.6 million shares traded on Wednesday.

  • GlobeNewswire

    Report: Exploring Fundamental Drivers Behind CSW Industrials, DMC Global, National HealthCare, Milestone Scientific, EnSync, and Trio-Tech International — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, Nov. 26, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • GlobeNewswire

    Milestone Scientific Announces Recent Presentations Featuring The Wand® STA

    Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Dr. Glassman, Chief Dental Officer for Dental Corp., and Dr. Eugene Casagrande, Director of International & Professional Relations, presented The Wand computer assisted anesthesia system and provided a hands-on demonstration at the Endodontics Solutions Program, a four day endodontics seminar in Toronto, Canada from November 1-4 2018. In addition, the Company announced that Dr. Casagrande presented The Wand STA at a forum hosted by the University of Florida College of Dentistry on October 31, 2018.